EyePoint Pharmaceuticals Announces Presentations at Eyecelerator 2023, American Academy of Ophthalmology Annual Meeting 2023 and Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conf

Go back to EyePoint Pharmaceuticals Announces Presentations at Eyecelerator 2023, American Academy of Ophthalmology Annual Meeting 2023 and Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conf
(NASDAQ: EYPT) Delayed: 14.69 +0.96 (6.99%)
Previous Close $13.73    52 Week High
Open $13.62    52 Week Low
Day High $14.81    P/E N/A 
Day Low $13.61    EPS
Volume 540,744